Abstract
Depression, anxiety, and substance-related and addictive disorders undermine healthy aging. Despite the stigma associated with being older, healthy aging has recently been the focus of research and a topic of media coverage. Interventions intended to assist with healthy aging are geared toward modifying risk factors for medical and psychiatric illnesses. These include increasing the amount of physical activity, decreasing alcohol consumption, maintaining social connections, and smoking cessation. The differential diagnosis of depression in older adults includes medical illnesses, dementia, and psychiatric problems such as bereavement and the behavioral and psychiatric symptoms of dementia (BPSD). Depression symptoms in older adults may go unrecognized due to the false idea that developing depression symptoms represents normal aging. Unlike depression, anxiety disorders in older adults may not appear the same as in younger cohorts. Anxious older adults are more likely to report somatic complaints rather than psychological distress. Substance-related and addictive disorders are yet another source of preventable suffering in older individuals that may be overlooked by clinicians due to age-related biases. The first step in the evaluation of older adults with symptoms of depression, anxiety, and substance-related and addictive disorders is conducting a careful investigation of possible underlying medical conditions which could be causing the symptoms. Psychotherapy and pharmacotherapy are the first-line treatments for all of these disorders.
This work was completed at the University of California, San Diego, in San Diego, CA. No research funding was received for research for this article, and the authors have no disclosures to report.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adams WL, Barry KL, Fleming MF. Screening for problem drinking in older primary care patients. JAMA. 1996;276(24):1964–196. https://doi.org/10.1001/jama.1996.03540240042028.
Adams KB, Sanders S, Auth EA. Loneliness and depression in independent living retirement communities: risk and resilience factors. Aging Ment Health. 2004;8:475–85.
Alexopoulos GS. Vascular depression hypothesis. Arch Gen Psychiatry. 1997;54:915.
Alexopoulos GS, Morimoto SS. The inflammation hypothesis in geriatric depression. Int J Geriatr Psychiatry. 2011;26:1109–18.
American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63:2227–46.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.
Baldwin D, Woods R, Lawson R, Taylor D. Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis. BMJ. 2011;342:d1199.
Bamidis P, Vivas A, Styliadis C, Frantzidis C, Klados M, Schlee W, Siountas A, Papageorgiou S. A review of physical and cognitive interventions in aging. Neurosci Biobehav Rev. 2014;44:206–20.
Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–7.
Beck J, Stanley MA, Zebb BJ. Characteristics of generalized anxiety disorder in older adults: a descriptive study. Behav Res Ther. 1996;34:225–34.
Beekman AT, Beurs ED, Balkom AJV, Deeg DJ, Dyck RV, Tilburg WV. Anxiety and depression in later life: co-occurrence and communality of risk factors. Am J Psychiatr. 2000;157:89–95.
Blake H, Mo P, Malik S, Thomas S. How effective are physical activity interventions for alleviating depressive symptoms in older people? A systematic review. Clin Rehabil. 2009;23:873–87.
Blazer DG, Hybels CF. Origins of depression in later life. Psychol Med. 2005;35:1241.
Bogunovic OJ, Greenfield SF. Practical geriatrics: use of benzodiazepines among elderly patients. Psychiatr Serv. 2004;55:233–5.
Bower ES, Wetherell JL, Mon T, Lenze EJ. Treating anxiety disorders in older adults. Harv Rev Psychiatry. 2015;23:329–42.
Brenes GA, Guralnik JM, Williamson JD, Fried LP, Simpson C, Simonsick EM, Penninx BWJH. The influence of anxiety on the progression of disability. J Am Geriatr Soc. 2005;53:34–9.
Brennan PL, Nichol AC, Moos RH. Older and younger patients with substance use disorders: outpatient mental health service use and functioning over a 12-month interval. Psychol Addict Behav. 2003;17(1):42–8.
Brodaty H, Hickie I, Mason C, Prenter L. A prospective follow-up study of ECT outcome in older depressed patients. J Affect Disord. 2000;60:101–11.
Bruce ML. Psychosocial risk factors for depressive disorders in late life. Biol Psychiatry. 2002;52:175–84.
Bruce ML, Have TRT, Reynolds CF III, Katz II, Schulberg HC, Mulsant BH, Brown GK, Mcavay GJ, Pearson JL, Alexopoulos GS. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients. JAMA. 2004;291:1081.
Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol. 2011;7:323–31.
Cacioppo JT, Hawkley LC, Kalil A, et al. Happiness and the invisible threads of social connection. In: Eid M, Larsen RJ, editors. The science of subjective well-being. New York: The Guilford Press; 2008. p. 195–219.
Canuto A, Weber K, Baetschi M, et al. Anxiety disorders in old age: psychiatric comorbidities, quality of life, and prevalence according to age, gender, and country. Am J Psychiatr. 2018;26:174–85.
Center for Substance Abuse Treatment. Substance abuse among older adults: Treatment Improvement Protocol (TIP) Series 26. Rockville: Substance Abuse and Mental Health Services Administration; 1998.
Charles ST, Reynolds CA, Gatz M. Age-related differences and change in positive and negative affect over 23 years. J Pers Soc Psychol. 2001;80:136–51.
Chessick CA, Allen MH, Thase ME, Angelo ABC Batista Miralha da Cunha, Kapczinski F, Lima MSD, Souza JJDS. Azapirones for generalized anxiety disorder. Cochrane Database Syst Rev. 2006. https://doi.org/10.1002/14651858.cd006115.
Cole MG, Dendukuri N. Risk factors for depression among community subjects: a systematic review and metaanalysis. Am J Psychiatry. 2003;160:1147–56.
Comijs HC, Nieuwesteeg J, Kok R, Marwijk HWV, Mast RCVD, Naarding P, Voshaar RCO, Verhaak P, Waal MWD, Stek ML. The two-year course of late-life depression; results from the Netherlands study of depression in older persons. BMC Psychiatry. 2015;15:20.
Conwell Y, Orden KV, Caine ED. Suicide in older adults. Psychiatr Clin N Am. 2011;34:451–68.
De Beurs E, Beekman A, Geerlings S, Deeg D, Van Dyck R, Van Tilburg W. On becoming depressed or anxious in late life: similar vulnerability factors but different effects on stressful life events. Br J Psychiatry. 2001;179:426–31.
Depp CA, Jeste DV. Definitions and predictors of successful aging: a comprehensive review of larger quantitative studies. Am J Geriatr Psychiatry. 2006;14:6–20.
Depping AM, Komossa K, Kissling W, Leucht S. Second-generation antipsychotics for anxiety disorders. Cochrane Database Syst Rev. 2010. https://doi.org/10.1002/14651858.cd008120.pub2.
Dias FLDC, Teixeira AL, Guimarães HC, Barbosa MT, Resende EDPF, Beato RG, Carmona KC, Caramelli P. Accuracy of the 15-item Geriatric Depression Scale (GDS-15) in a community-dwelling oldest-old sample: the Pietà Study. Trends Psychiatry Psychother. 2017;39:276–9.
Diefenbach GJ, Goethe J. Clinical interventions for late-life anxious depression. Clin Interv Aging. 2006;1:41–50.
Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF. Late-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013;202:329–35.
Djernes JK. Prevalence and predictors of depression in populations of elderly: a review. Acta Psychiatr Scand. 2006;113:372–87.
Baldwin D, Woods R, Lawson R, Taylor D. Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis. BMJ. 2011;342:d1718.
Fortney JC, Booth BM, Blow FC, et al. The effects of travel barriers and age on utilization of alcoholism treatment aftercare. Am J Drug Alcohol Abuse. 1995;21(3):391–407.
Frasure-Smith N, Lesperance F, Juneau M, Talajic M, Bourassa MG. Gender, depression, and one-year prognosis after myocardial infarction. Psychosom Med. 1999;61:26–37.
Geriatric Depression Scale. SpringerReference. https://doi.org/10.1007/springerreference_184613.
Gfroerer J, Penne M, Pemberton M, Folsom R. Substance abuse treatment need among older adults in 2020: the impact of the aging baby-boom cohort. Drug Alcohol Depend. 2003;69:127–35.
Goldberg DP, Huxley P. Common mental disorders: a biosocial model. London: Routledge; 1992.
Grant JE, Odlaug BL, Chamberlain SR. Gambling disorder, DSM-5 criteria and symptom severity. Compr Psychiatry. 2017;75:1–5. https://doi.org/10.1016/j.comppsych.2017.02.006.
Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JRT, Ballenger JC, Fyer AJ. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry. 1999;60:427–35.
Greenberg SA. The Geriatric Depression Scale (GDS). Try this: best practices in nursing care to older adults. 2019;4:1.
Guaiana G, Barbui C, Churchill R, Cipriani A, Mcguire H. Hydroxyzine for generalised anxiety disorder. Cochrane Database Syst Rev. 2007. https://doi.org/10.1002/14651858.cd006815.
Gulpers B, Ramakers I, Hamel R, Köhler S, Voshaar RO, Verhey F. Anxiety as a predictor for cognitive decline and dementia: a systematic review and meta-analysis. Am J Geriatr Psychiatry. 2016;24:823–42.
Haigh EA, Bogucki OE, Sigmon ST, Blazer DG. Depression among older adults: a 20-year update on five common myths and misconceptions. Am J Geriatr Psychiatry. 2018;26:107–22.
Hall J, Kellett S, Berrios R, Bains MK, Scott S. Efficacy of cognitive behavioral therapy for generalized anxiety disorder in older adults: systematic review, meta-analysis, and meta-regression. Am J Geriatr Psychiatry. 2016;24:1063–73.
Harmell AL, Jeste D, Depp C. Strategies for successful aging: a research update. Curr Psychiatry Rep. 2014;16:476–87.
Hendriks G-J, Kampman M, Keijsers GPJ, Hoogduin CAL, Voshaar RCO. Cognitive-behavioral therapy for panic disorder with agoraphobia in older people: a comparison with younger patients. Depress Anxiety. 2014;31:669–77.
Hing N, Russell AMT. Psychological factors, sociodemographic characteristics, and coping mechanisms associated with the self-stigma of problem gambling. J Behav Addict. 2017;6(3):416–24. https://doi.org/10.1556/2006.6.2017.056.
Hong S-I, Sacco P, Cunningham-Williams RM. An empirical typology of lifetime and current gambling behaviors: association with health status of older adults. Aging Ment Health. 2009;13(2):265–73. https://doi.org/10.1080/13607860802459849.
Hybels CF, Blazer DG. Epidemiology of late-life mental disorders. Clin Geriatr Med. 2003;19:663–96.
Jeste DV. Feeling fine at a hundred and three. Am J Prev Med. 2005;28:323–4.
Kabacoff RI, Segal DL, Hersen M, Hasselt VBV. Psychometric properties and diagnostic utility of the Beck Anxiety Inventory and the state-trait anxiety inventory with older adult psychiatric outpatients. J Anxiety Disord. 1997;11:33–47.
Kapczinski F, Souza JJDS, da Cunha Angelo ABC Batista Miralha, Schmitt RR. Antidepressants for generalised anxiety disorder (GAD). Cochrane Database Syst Rev. 2003. https://doi.org/10.1002/14651858.cd003592.
Keller MB. A comparison of Nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000;342:1462.
Kennedy GJ, Ceïde ME. Screening older adults for mental disorders. Clin Geriatr Med. 2018;34:69–79.
Kessler RC, Birnbaum H, Bromet E, Hwang I, Sampson N, Shahly V. Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R). Psychol Med. 2009;40:225.
Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen H-U. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012;21:169–84.
Koenig HG, Blazer DG. Epidemiology of geriatric affective disorders. Clin Geriatr Med. 1992;8:235–51.
Kornstein SG. Gender differences in depression: implications for treatment. J Clin Psychiatry. 1997;58(Suppl 15):12.
Krasucki C, Howard R, Mann A. Anxiety and its treatment in the elderly. Int Psychogeriatr. 1999;11:25–45.
Kroenke K, Spitzer RL, Williams JBW. The PHQ-9. J Gen Intern Med. 2001;16:606–13.
Kuerbis AN, Sacco P. A review of existing treatments for substance abuse among the elderly and recommendations for future directions. Subst Abuse. 2013;7:13–37.
Kuerbis A, Sacco P, Blazer DG, Moore AA. Substance abuse among older adults. Clin Geriatr Med. 2014;30(3):629–54.
Lavretsky H, Reinlieb M, Cyr NS, Siddarth P, Ercoli LM, Senturk D. Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial. Am J Psychiatr. 2015;172:561–9.
Lenze EJ, Mulsant BH, Blumberger DM, et al. Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial. Lancet. 2015;386:2404–12.
Licht-Strunk E, Windt DAVD, Marwijk HWV, Haan MD, Beekman AT. The prognosis of depression in older patients in general practice and the community. A systematic review. Fam Pract. 2007;24:168–80.
Lieverse R, Someren EJWV, Nielen MMA, Uitdehaag BMJ, Smit JH, Hoogendijk WJG. Bright light treatment in elderly patients with nonseasonal major depressive disorder. Arch Gen Psychiatry. 2011;68:61.
Lister JJ, Milosevic A, Ledgerwood DM. Psychological characteristics of problem gamblers with and without mood disorder. Can J Psychiatry. 2015;60(8):369–76.
Lundorff M, Holmgren H, Zachariae R, Farver-Vestergaard I, O’Connor M. Prevalence of prolonged grief disorder in adult bereavement: a systematic review and meta-analysis. J Affect Disord. 2017;212:138–49.
Lyness JM, King DA, Cox C, Yoediono Z, Caine ED. The importance of subsyndromal depression in older primary care patients: prevalence and associated functional disability. J Am Geriatr Soc. 1999;47:647–52.
Medeiros GC, Leppink E, Yaemi A, Mariani M, Tavares H, Grant J. Gambling disorder in older adults: a cross-cultural perspective. Compr Psychiatry. 2015;58:116–21. https://doi.org/10.1016/j.comppsych.2014.12.021.
Mehta M, Whyte E, Lenze E, Hardy S, Roumani Y, Subashan P, Huang W, Studenski S. Depressive symptoms in late life: associations with apathy, resilience and disability vary between young-old and old-old. Int J Geriatr Psychiatry. 2008;23:238–43.
Mitchell AJ, Subramaniam H. Prognosis of depression in old age compared to middle age: a systematic review of comparative studies. Am J Psychiatr. 2005;162:1588–601.
Mittmann N, Herrmann N, Shulman KI, Silver IL, Busto UE, Borden EK, Naranjo CA, Shear NH. The effectiveness of antidepressants in elderly depressed outpatients. J Clin Psychiatry. 1999;60:690–7.
Montgomery S, Chatamra K, Pauer L, Whalen E, Baldinetti F. Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder. Br J Psychiatry. 2008;193:389–94.
Moreno-Peral P, Conejo-Cerón S, Rubio-Valera M, et al. Effectiveness of psychological and/or educational interventions in the prevention of anxiety. JAMA Psychiat. 2017;74:1021–9.
Mottram PG, Wilson K, Strobl JJ. Antidepressants for depressed elderly. Cochrane Database Syst Rev. 2006. https://doi.org/10.1002/14651858.cd003491.pub2.
Mughal S, Siddiqui W. Grief reaction. Treasure Island: StatPearls Publishing; 2018.. PMID: 29939609.
Nelson JC. Duloxetine for the treatment of major depressive disorder in older patients. Am J Geriatr Psychiatr. 2005;13:227–35.
Parke A, Griffiths M, Pattinson J, Keatley D. Age-related physical and psychological vulnerability as pathways to problem gambling in older adults. J Behav Addict. 2018;7(1):137–45. https://doi.org/10.1556/2006.7.2018.18.
Pinquart M. Treatments for later-life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy. Am J Psychiatr. 2006;163:1493.
Porensky EK, Dew MA, Karp JF, Skidmore E, Rollman BL, Shear MK, Lenze EJ. The burden of late-life generalized anxiety disorder: effects on disability, health-related quality of life, and healthcare utilization. Am J Geriatr Psychiatry. 2009;17:473–82.
Ravindran LN, Stein MB. The pharmacologic treatment of anxiety disorders. J Clin Psychiatry. 2010;71:839–54.
Reifler BV, Bruce ML. Home-based mental health services for older adults: a review of ten model programs. Am J Geriatr Psychiatry. 2014;22:241–7.
Reynolds K, Pietrzak RH, El-Gabalawy R, Mackenzie CS, Sareen J. Prevalence of psychiatric disorders in U.S. older adults: findings from a nationally representative survey. World Psychiatry. 2015;14:74–81.
Rogalsky C, Vidal C, Li X, Damasio H. Risky decision-making in older adults without cognitive deficits: an fMRI study of VMPFC using the Iowa gambling task. Soc Neurosci. 2012;7(2):178–90. https://doi.org/10.1080/17470919.2011.588340.
Rovner BW, Ganguli M. Depression and disability associated with impaired vision: the MoVIES project. J Am Geriatr Soc. 1998;46:617–9.
Sacco P, Kuerbis A. Older adults. In: Vaughn MG, Perron BE, editors. Social work practice in the addictions, vol. 2013. New York: Springer; 2013. p. 213–29.
Sajatovic M, Chen P, Young R. Chapter 9: rating scales in bipolar disorder. In: Tohen M, Bowden CL, Nierenberg AA, Geddes JR, editors. Clinical trial design challenges in mood disorders. Amsterdam: Elsevier; 2015. p. 105–36.
Schonfeld L, King-Kallimanis BL, Duchene DM, Etheridge RL, Herrera JR, Barry KL, Lynn N. Screening and brief intervention for substance misuse among older adults: the Florida BRITE project. Am J Public Health. 2010;100:108–14.
Schultz SK, Arndt S, Liesveld J. Locations of facilities with special programs for older substance abuse clients in the US. Int J Geriatr Psychiatry. 2003;18(9):839–43.
Shear MK, Wang Y, Skritskaya N, Duan N, Mauro C, Ghesquiere A. Treatment of complicated grief in elderly persons. JAMA Psychiat. 2014;71:1287.
Sheikh JI, Yesavage JA. Geriatric Depression cale (GDS). Clin Gerontol. 1986;5:165–73.
Solai LK, Mulsant BH, Pollock BG. Selective serotonin reuptake inhibitors for late-life depression. Drugs Aging. 2001;18:355–68.
Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing generalized anxiety disorder. Arch Intern Med. 2006;166:1092–7.
Steer RA, Willman M, Kay PAJ, Beck AT. Differentiating elderly medical and psychiatric outpatients with the Beck Anxiety Inventory. Assessment. 1994;1:345–51.
Subramaniam M, Chong SA, Satghare P, Browning CJ, Thomas S. Gambling and family: a two-way relationship. J Behav Addict. 2017;6(4):689–98. https://doi.org/10.1556/2006.6.2017.082.
Thomas ML, Kaufmann CN, Palmer BW, Depp CA, Martin AS, Glorioso DK, Thompson WK, Jeste DV. Paradoxical trend for improvement in mental health with aging. J Clin Psychiatry. 2016;77:1019–25.
Thompson E. Hamilton rating scale for anxiety (HAM-A). Occup Med. 2015;65(7):601.
Thorp SR, Ayers CR, Nuevo R, Stoddard JA, Sorrell JT, Wetherell JL. Meta-analysis comparing different behavioral treatments for late-life anxiety. Am J Geriatr Psychiatry. 2009;17:105–15.
Unützer J, Park M. Older adults with severe, treatment-resistant depression. JAMA. 2012;308:909.
Veer-Tazelaar PJV, Marwijk HWJV, Oppen PV, Hout HPJV, Horst HEVD, Cuijpers P, Smit F, Beekman ATF. Stepped-care prevention of anxiety and depression in late life. Arch Gen Psychiatry. 2009;66:297–304.
Vink D, Aartsen MJ, Schoevers RA. Risk factors for anxiety and depression in the elderly: a review. J Affect Disord. 2008;106:29–44.
Wetherell JL, Petkus AJ, Mcchesney K, Stein MB, Judd PH, Rockwell E, Sewell DD, Patterson TL. Older adults are less accurate than younger adults at identifying symptoms of anxiety and depression. J Nerv Ment Dis. 2009;197:623–6.
Whyte EM, Mulsant BH, Vanderbilt J, Dodge HH, Ganguli M. Depression after stroke: a prospective epidemiological study. J Am Geriatr Soc. 2004;52:774–8.
Wild B, Eckl A, Herzog W, Niehoff D, Lechner S, Maatouk I, Schellberg D, Brenner H, Müller H, Löwe B. Assessing generalized anxiety disorder in elderly people using the GAD-7 and GAD-2 scales: results of a validation study. Am J Geriatr Psychiatry. 2014;22:1029–38.
Wittchen H-U, Strehle J, Gerschler A, et al. Measuring symptoms and diagnosing mental disorders in the elderly community: the test-retest reliability of the CIDI65. Int J Methods Psychiatr Res. 2014;24:116–29.
Wittouck C, Autreve SV, Jaegere ED, Portzky G, Heeringen KV. The prevention and treatment of complicated grief: a meta-analysis. Clin Psychol Rev. 2011;31:69–78.
Wolitzky-Taylor KB, Castriotta N, Lenze EJ, Stanley MA, Craske MG. Anxiety disorders in older adults: a comprehensive review. Depress Anxiety. 2010;27:190–211.
Yesavage JA, Sheikh JI. 9/Geriatric Depression Scale (GDS). Clin Gerontol. 1986;5:165–73.
Zalta AK. A meta-analysis of anxiety symptom prevention with cognitive-behavioral interventions. J Anxiety Disord. 2011;25:749–60.
Zhang X, Norton J, Carrière I, Ritchie K, Chaudieu I, Ancelin M-L. Risk factors for late-onset generalized anxiety disorder: results from a 12-year prospective cohort (the ESPRIT study). Transl Psychiatry. 2015;5:e536. https://doi.org/10.1038/tp.2015.31.
Zohar J, Westenberg HGM. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand. 2000;101:39–49.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Yagudayeva, R., Matialeu, L., Schupper, A.J., Onodera, K.M., Sewell, D.D. (2019). Promoting Healthy Aging Through Recognition and Treatment of Psychiatric Disorders in Older Adults. In: Coll, P. (eds) Healthy Aging. Springer, Cham. https://doi.org/10.1007/978-3-030-06200-2_24
Download citation
DOI: https://doi.org/10.1007/978-3-030-06200-2_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-06199-9
Online ISBN: 978-3-030-06200-2
eBook Packages: MedicineMedicine (R0)